Valaciclovir clinical trials

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

This study is testing a new gene therapy, TGX-007, for an aggressive type of brain tumour called glioblastoma. It aims to find the safest dose and see how well it works. TGX-007 helps the body fight the cancer by working with a common antiviral medicine, valaciclovir.